Dr. José Luis Molinuevo will be presenting the EPAD Project during this conference.

World Alzheimer’s Day, September 21st of each year, is a day on which Alzheimer’s organizations around the world concentrate their efforts on raising awareness about Alzheimer’s and dementia. Alzheimer’s disease is the most common form of dementia, a group of disorders that impairs mental functioning. Every 68 seconds, someone develops Alzheimer’s disease. At current rates,…

During the CNS Summit 2015, EPAD WP1 co-lead and EPAD Executive Committee Member, Andy Satlin from Eisai inc. will be presenting an update on EPAD. Make sure not to miss this!

The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the…

During the session of 'Prevention of Alzheimer's dementia', Craig Ritchie will present the EPAD Project and the need for a new disease understanding followed by Edo Richard, EPAD's ethical expert, who will discuss ethical issues raised by secondary prevention trials. Please note that during the conference, several EPAD members will be presenting. Make sure not…

The 41st ESNR annual meeting, 25th advanced course in diagnostic neuroradiology and 10th advanced course in interventional neuroradiology will take place in Rotterdam in late September. EPAD's Silvia Ingala of the Vumc Department of Radiology is presenting a poster entitled "Brain imaging for secondary prevention of Alzheimer’s dementia: the EPAD study".    

Three EPAD abstracts have been accepted at this year's IMI Scientific Symposium in Brussels on 22 and 23 October 2018. Oral presentation, October 22nd 11:30 – 12:15 “Predicting Cognitive Decline through Structural MRI biomarkers: Results from the EMIF-AD Biomarker Discovery Study” EPAD - Ingala Silvia, VU Medical Center Poster 45 “Altering disease course before symptom…

We are delighted to announce that EPAD co-coordinator Professor Craig Ritchie will deliver an oral presentation at the 11th Clinical Trials on Alzheimer's Disease (CTAD) on 27th October at 3.15pm. The goal of CTAD 2018 is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and…

28th Alzheimer Europe Conference, in collaboration with CEAFA and Fundación Alzheimer España, will be held in Barcelona from 29 to 31 October 2018. This year’s conference theme is “Making dementia a European priority”. We are pleased to announce that EPAD's Jose Luis Molinuevo, Scientific Director of the Barcelona Beta Research Centre, will give the opening lecture…